Accuracy of expected risk of Down syndrome using the second-trimester triple test

被引：0
|
作者：
Meier, C [1 ]
Huang, TH [1 ]
Wyatt, PR [1 ]
Summers, AM [1 ]
机构：
[1] N York Gen Hosp, Toronto, ON M2K 1E1, Canada
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：653 / 655
页数：3
相关论文
共 50 条
  • [41] Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome
    Sermondade, Nathalie
    Dreux, Sophie
    Oury, Jean-Francois
    Muller, Francoise
    PRENATAL DIAGNOSIS, 2009, 29 (08) : 814 - 815
  • [42] Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population
    Rozenberg, Patrick
    Bussieres, Laurence
    Chevret, Sylvie
    Bernard, Jean Pierre
    Malagrida, Lydia
    Cuckle, Howard
    Chabry, Chantal
    Durand-Zaleski, Isabelle
    Bidat, Laurent
    Lacroix, Isabelle
    Moutis, Max
    Roger, Marc
    Jacquemot, Christine
    Bault, Jean Philippe
    Boukobza, Philippe
    Boccara, Patrick
    Vialard, Francois
    Giudicelli, Yves
    Ville, Yves
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (05) : 1379 - 1387
  • [43] Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome
    Muller, F
    Dreux, S
    Lemeur, A
    Sault, C
    Desgrès, J
    Bernard, MA
    Giorgetti, C
    Lemay, C
    Mirallié, S
    Beauchet, A
    PRENATAL DIAGNOSIS, 2003, 23 (13) : 1073 - 1076
  • [44] Second-trimester maternal serum invasive trophoblast antigen: A marker for down syndrome screening
    Pandian, R
    Cole, LA
    Palomaki, GE
    CLINICAL CHEMISTRY, 2004, 50 (08) : 1433 - 1435
  • [45] Interference in the autoDELFIA® hAFP immunoassay and effect on second-trimester Down's syndrome screening
    Taylor, Kevin P.
    Goodburn, Sandy
    Halsall, David J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 412 - 413
  • [46] Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker
    Rode, L
    Wojdemann, KR
    Shalmi, AC
    Larsen, SO
    Sundberg, K
    Norgaard-Pedersen, B
    Christiansen, M
    Tabor, A
    PRENATAL DIAGNOSIS, 2003, 23 (07) : 593 - 598
  • [47] Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study
    Audibert, F
    Dommergues, M
    Benattar, C
    Taieb, J
    Thalabard, JC
    Frydman, R
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (01) : 26 - 31
  • [48] First- and second-trimester screening - Detection of aneuploidies other than down syndrome
    Breathnach, Fionnuala M.
    Malone, Fergal D.
    Lambert-Messerlian, Geralyn
    Cuckle, Howard S.
    Porter, T. Flint
    Nyberg, David A.
    Comstock, Christine H.
    Saade, George R.
    Berkowitz, Richard L.
    Klugman, Susan
    Dugoff, Lorraine
    Craigo, Sabrina D.
    Timor-Tritsch, Ilan E.
    Carr, Stephen R.
    Wolfe, Honor M.
    Tripp, Tara
    Bianchi, Diana W.
    D'Alton, Mary E.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (03): : 651 - 657
  • [49] Strict glycemic control in diabetic pregnancy - implications for second-trimester screening for Down syndrome
    Peled, Y
    Gilboa, Y
    Perri, T
    Shohat, M
    Chen, R
    Bar, J
    Hod, M
    Pardo, J
    PRENATAL DIAGNOSIS, 2003, 23 (11) : 888 - 890
  • [50] The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome
    Kadir, RA
    Economides, DL
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 9 (04) : 244 - 247
12345